Similar results were observed in another lung carcinoma cell line H358 (Figure S1A, Supporting Information), suggesting that PRMT5 might potentiate STAT3 activation induced by autocrine IL‐6 in lung carcinoma cells. Here, IL6 is linked to lung carcinoma.